Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration

Bibliography

• McKay IA. Growth factors: a practical approach. IRL Press: Oxford; 1993
   Google Scholar
• Boontheekul T, Mooney DJ. Protein-based signaling systems in tissue engineering. Curr Opin Biotech 2003;14:559-65
   PubMed Web of Science ®Google Scholar
• Iwaniec UT, Magee KA, Mitova-Caneva NG, et al. Bone anabolic effects of subcutaneous treatment with basic fibroblast growth factor alone and in combination with estrogen in osteopenic ovariectomized rats. Bone 2003;33:380-38
   PubMed Web of Science ®Google Scholar
• Tao Y, Black IB, Dicicco-Bloom E. Neurogenesis in neuronatal rat brain is regulated by peripheral injection of basic fibroblast growth factor (bFGF). J Comp Neurol 1996;376:653-63
   PubMed Web of Science ®Google Scholar
• Schifitto G, Yiannoutsos C, Simpson DM, et al. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology 2001;57:1313-6
   PubMed Web of Science ®Google Scholar
• Ueda Y, Yamagishi T, Ikeya H, et al. A novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo. Anticancer Res 2004;24:3009-17
   PubMed Web of Science ®Google Scholar
• Rosen LS. Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers. Cancer Control 2002;9:36-44
   PubMedGoogle Scholar
• Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005;9:777-94
   PubMed Web of Science ®Google Scholar
• Capila I, Linhardt RJ. Heparin–protein interactions. Angew Chem Int Ed 2002;41:390-412
   Web of Science ®Google Scholar
• Baldwin SP, Saltzman WM. Materials for protein delivery in tissue engineering. Adv Drug Deliv Rev 1998;33:71-86
   PubMed Web of Science ®Google Scholar
• Hock JM, Canalis E, Centrella M. Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology 1990;126:421-6
   PubMed Web of Science ®Google Scholar
• Joyce M, Roberts A, Sporn M, et al. Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 1990;110:2195-207
   PubMed Web of Science ®Google Scholar
• Lu L, Stamatas GN, Mikos AG. Controlled release of transforming growth factor β1 from biodegradable polymer microparticles. J Biomed Mater Res 2000;50:440-51
   PubMed Web of Science ®Google Scholar
• Peter SJ, Lu L, Kim DJ, et al. Effects of transforming growth factor 1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res 2000;50:452-62
   PubMed Web of Science ®Google Scholar
• Cleek RL, Rege AA, Denner LA, et al. Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. J Biomed Mater Res 1997;35:525-30
   PubMed Web of Science ®Google Scholar
• Dailey L, Ambrosetti D, Mansukhani A, et al. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 2005;16:233-47
   PubMed Web of Science ®Google Scholar
• Perets A, Baruch Y, Weisbuch F, et al. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A 2003;65A:489-97
   Web of Science ®Google Scholar
• Suetomi T, Hisasue SI, Sato Y, et al. Effect of basic fibroblast growth factor incorporating cleatin microspheres on erectile function in the diabetic rat. J Urol 2005;173:1423-8
   PubMed Web of Science ®Google Scholar
• Rogers RS, Graziottin TM, Lin CS, et al. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res 2003;15:26-37
   PubMed Web of Science ®Google Scholar
• Dai Q, Silverstein AD, Davies MG, et al. Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits. J Urol 2003;170:664-8
   PubMed Web of Science ®Google Scholar
• Bochinski D, Hsieh PS, Nunes L, et al. Effect of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 complex in cavernous nerve cryoablation. Int J Impot Res 2004;16:418-23
   PubMed Web of Science ®Google Scholar
• Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol 2001;280:c1358-66
   PubMed Web of Science ®Google Scholar
• Zelzer E, McLean W, Ng YS, et al. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 2002;129(8):1893-904
   PubMed Web of Science ®Google Scholar
• Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999;19:5731-40
   PubMed Web of Science ®Google Scholar
• Oberg-Welsh C, Sandler S, Andersson A, et al. Effects of vascular endothelial growth factor on pancreatic duct cell replication and the insulin production of fetal islet-like cell clusters in vitro. Mol Cell Endocrinol 1997;126:125-32
   PubMed Web of Science ®Google Scholar
• Banai S, Jaklitsch MT, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-9
   PubMed Web of Science ®Google Scholar
• Pearlman JD, Hibberd MG, Chuang ML, et al. Magnetic resonance mapping demonstrate benefits of VEGF induced myocardial angiogenesis. Nat Med 1995;1:1085-9
   PubMed Web of Science ®Google Scholar
• Harada K, Friedman M, Lopez JJ, et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol 1996;270:1791-802
   PubMed Web of Science ®Google Scholar
• Lee RJ, Springer ML, Blanco-Bose WE, et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000;102:898-901
   PubMed Web of Science ®Google Scholar
• King TW, Patrick CW Jr. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. J Biomed Mater Res 2000;51:383-90
   PubMed Web of Science ®Google Scholar
• Cleland JL, Duenas ET, Park A, et al. Development of poly(D,L-lactide–coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J Control Release 2001;72:13-24
   PubMed Web of Science ®Google Scholar
• Faranesh AZ, Nastley MT, Cruz CPD, et al. Theoretical and experimental investigation of the VASO contrast mechanism. Magn Reson Med 2004;51:1265-73
   PubMed Web of Science ®Google Scholar
• Norton LW, Tegnella E, Toporekb SS, et al. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. Biomaterials 2005;26:3285-97
   PubMed Web of Science ®Google Scholar
• Conn G, Soderman DD, Schaeffer MT, et al. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 1990;87:1323-7
   PubMed Web of Science ®Google Scholar
• Nissen NN, Polverini PJ, Koch AE, et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative. phase of wound healing. Am J Pathol 1998;152:1445-52
   PubMed Web of Science ®Google Scholar
• Shibayama E, Koizumi H. Cellular localization of the trk neurotrophin receptor family in human non-neuronal tissues. Am J Pathol 1996;148:1807-18
   PubMed Web of Science ®Google Scholar
• Camarata PJ, Suryanarayanan R, Turner DA, et al. Sustained release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery 1992;30:313-9
   PubMed Web of Science ®Google Scholar
• Mittal S, Cohen A, Maysinger D. In vitro effects of brain derived neurotrophic factor released from microspheres. Neuroreport 1994;5:2577-82
   PubMed Web of Science ®Google Scholar
• Krewson CE, Dause R, Mak M, et al. Stabilization of nerve growth factor in controlled release polymers and in tissue. J Biomater Sci Polym Ed 1996;8:103-17
   PubMed Web of Science ®Google Scholar
• Péan JM, Menei P, Morel O, et al. Intraseptal implantation of NGF-releasing microspheres promotes the survival of axotomized cholinergic neurons. Biomaterials 2000;21:2097-101
   PubMed Web of Science ®Google Scholar
• Montero CN, Hefti F. Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment. J Neurosci 1998;8:2986-99
   Google Scholar
• Tatard VM, Venier-Julienne MC, Saulnier P, et al. Pharmacologically active microcarriers: a tool for cell therapy. Biomaterials 2005;26:3727-37
   PubMed Web of Science ®Google Scholar
• Cao X, Shoichet MS. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials 1999;20:329-39
   PubMed Web of Science ®Google Scholar
• Piotrowicza A, Shoichet MS. Nerve guidance channels as drug delivery vehicles. Biomaterials 2006;27:2018-27
   PubMed Web of Science ®Google Scholar
• Xu X, Yu H, Gao S, et al. Polyphosphoester microspheres for sustained release of biologically active nerve growth factor. Biomaterials 2002;23:3765-72
   PubMed Web of Science ®Google Scholar
• Xu X, Yee WC, Hwang PYK, et al. Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits. Biomaterials 2003;24:2405-12
   PubMed Web of Science ®Google Scholar
• Wang S, Wan AC, Xu X, et al. A new nerve guide conduit material composed of a biodegradable poly(phosphoester). Biomaterials 2001;22:1157-69
   PubMed Web of Science ®Google Scholar
• Jee KS, Park HD, Park KD, et al. Heparin conjugated polylactide as a blood compatible materials. Biomacromolecules 2004;5:1877-81
   PubMed Web of Science ®Google Scholar
• Go DH, Joung YK, Park SY, et al. Heparin-conjugated star-shaped PLA for improved biocompatibility. J Biomed Mater Res A 2008;86A:842-8
   Web of Science ®Google Scholar
• Jeon O, Kang SW, Lim HW, et al. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials 2006;27:1598-607
   PubMed Web of Science ®Google Scholar
• Kim SK, Lee EH, Vaishali B, et al. Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates. J Control Release 2005;105:32-42
   PubMed Web of Science ®Google Scholar
• Moon HT, Lee YK, Han JK, et al. A novel formulation for controlled release of heparin-DOCA conjugate dispersed as nanoparticles in polyurethane film. Biomaterials 2001;22:281-9
   PubMed Web of Science ®Google Scholar
• Lee DY, Kim SK, Kim YS, et al. Suppression of angiogenesis and tumor growth by orally active deoxycholic acid-heparin conjugate. J Control Release 2007;118:310-7
   PubMed Web of Science ®Google Scholar
• Lee JS, Go DH, Bae JW, et al. Synthesis and characterization of heparin conjugated Tetronic-PCL copolymer for protein drug delivery. Curr Appl Phys 2007;7(Suppl 1):e49-e52
   Google Scholar
• Lee JS, Go DH, Bae JW, et al. Heparin conjugated polymeric micelle for long-term delivery of basic fibroblast growth factor. J Control Release 2007;117:204-9
   PubMed Web of Science ®Google Scholar
• Lee JS, Bae JW, Joung YK, et al. Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle. Int J Pharm 2008;346:57-63
   PubMed Web of Science ®Google Scholar
• Choi SH, Lee JH, Choi SM, et al. Thermally reversible Pluronic/heparin nanocapsules exhibiting 1000-fold volume transition. Langmuir 2006;22:1758-62
   PubMed Web of Science ®Google Scholar
• Qiu GM, Xu YY, Zhu BK, et al. Novel, fluorescent, magnetic, polysaccharide-based microsphere for orientation, tracing, and anticoagulation: preparation and characterization. Biomacromolecules 2005;6:1041-7
   PubMed Web of Science ®Google Scholar
• Passirani C, Barratt G, Devissaguet JP, et al. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly (methyl methacrylate) with the complement system. Life Sci 1998;62:775-85
   PubMed Web of Science ®Google Scholar
• Chung YI, Tae G, Yuk SH. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. Biomaterials 2006;27:2621-6
   PubMed Web of Science ®Google Scholar
• Sahli A, Cansell M, Tapon-Bretaudiére J, et al. The stability of heparin-coated liposomes in plasma and their effect on its coagulation. Colloids Surf B 1998;10:205-15
   Web of Science ®Google Scholar
• Na K, Kim SW, Park KS, et al. Heparin/poly(l-lysine) nanoparticle-coated polymeric microspheres for stem-cell therapy. J Am Chem Soc 2007;129:5788-9
   PubMed Web of Science ®Google Scholar
• Chinen N, Tanihara M, Nakagawa M, et al. Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release. J Biomed Mater Res 2003;67A:61-8
   Web of Science ®Google Scholar
• Andersson M, Loroth JE. Small particles of a heparin/chitosan complex prepared from a pharmaceutically acceptable microemulsion. Int J Pharm 2003;257:305-9
   PubMed Web of Science ®Google Scholar
• Rajangam K, Behanna HA, Hui MJ, et al. Heparin binding nanostructures to promote growth of blood vessels. Nano Lett 2006;6(9):2086-90
   PubMed Web of Science ®Google Scholar
• Thompson LD, Pantoliano MW, Springer BA. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. Biochemistry 1994;33:3831-40
   PubMed Web of Science ®Google Scholar
• Freire E, Mayorga OL, Straume M. Isothermal titration calorimetry. Anal Chem 1990;62:A950-9
   Web of Science ®Google Scholar
• Mach H, Volkin DB, Burke CJ, et al. Nature of the interaction of heparin with acidic fibroblast growth factor. Biochemistry 1993;32:5480-9
   PubMed Web of Science ®Google Scholar
• Gitay-Goren H, Soker S, Vladovsky I, et al. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 1992;267:6093-8
   PubMed Web of Science ®Google Scholar
• Bussolino F, DiRenzo MF, Ziche M, et al. Hepatocyte growth. factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-41
   PubMed Web of Science ®Google Scholar
• Naka D, Ishii T, Shimomura T, et al. Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes. Exp Cell Res 1993;209:317-24
   PubMed Web of Science ®Google Scholar
• Palladino MA, Morris RE, Starnes HF, et al. The transforming growth factor-beta. A new family of immunoregulatory molecules. Ann NY Acad Sci 1990;593:181-7
   PubMed Web of Science ®Google Scholar
• McCaffrey TA, Falcone DJ, Du B. Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1. J Cell Physiol 1992;152:430-40
   PubMed Web of Science ®Google Scholar
• Thompson SA, Higashiyama S, Wood K, et al. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin. J Biol Chem 1994;269:2541-9
   PubMed Web of Science ®Google Scholar
• Feyzi E, Lustig F, Fager G, et al. Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain. J Biol Chem 1997;272:5518-24
   PubMed Web of Science ®Google Scholar
• Langer R. Drug delivery systems. XVI(9). MRS Bull; 1991
   Google Scholar
• Kabanova AV, Batrakova EV, Alakhov VY. Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 2002;82:189-212
   PubMed Web of Science ®Google Scholar
• Malmsten M. Surfactants and polymers in: drug delivery. New York: Elsevier; 2000
   Google Scholar
• Moghimi SM, Hunter AC. Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends Biotechnol 2000;18:412-20
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Alakhov VY. Amphiphilic block copolymers: self-assembly and applications. New York: Elsevier; 2000
   Google Scholar
• Matthew JE, Nazario YL, Roberts SC, et al. Effect of mammalian cell culture medium on the gelation properties of Pluronic® F127. Biomaterials 2002;23:4615-9
   PubMed Web of Science ®Google Scholar
• Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm 1999;185:129-88
   PubMed Web of Science ®Google Scholar
• Nimni ME. Polypeptide growth factors: targeted delivery systems. Biomaterials 1997;18:1201-25
   PubMed Web of Science ®Google Scholar
• Salvay DM, Shea LD. Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol Biosyst 2006;2:36-48
   PubMed Web of Science ®Google Scholar
• Cho TJ, Gerstenfeld LC, Einhorn TA. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 2002;17:513-20
   PubMed Web of Science ®Google Scholar
• Richardson TP, Peters MC, Ennett AB, et al. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001;19:1029-34
   PubMed Web of Science ®Google Scholar
• Schmidmaier G, Wildemann B, Gabelein T, et al. Synergistic effect of IGF-I and TGF β1 on: fracture healing in rats single versus combined application of IGF-I and TGF β1. Acta Orthop Scand 2003;74:604-10
   PubMed Web of Science ®Google Scholar
• Simmons CA, Alsberg E, Hsiong S, et al. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004;35:562-9
   PubMed Web of Science ®Google Scholar
• Vonau RL, Bostrom MP, Aspenberg P, et al. Combination of growth factors inhibits bone ingrowth in the bone harvest chamber. Clin Orthop 2001;386:243-51
   PubMedGoogle Scholar
• Song S, Ewald AJ, Stallcup W, et al. PDGFR beta + perivascular progenitor cells in tumors regulate pericyte differentiation and vascular survival. Nat Cell Biol 2005;7:870-9
   PubMed Web of Science ®Google Scholar
• Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat 1999;194:1-14
   PubMed Web of Science ®Google Scholar
• Ahmed Z, Brown RA, Ljungberg C, et al. Nerve growth factor enhances peripheral nerve regeneration in non-human primates. Scand J Plast Reconstr Hand Surg 1999;33:393-401
   PubMed Web of Science ®Google Scholar
• Piotrowicz A, Shoichet MS. Nerve guidance channels as drug delivery vehicles. Biomaterials 2006;27:2018-27
   PubMed Web of Science ®Google Scholar
• Petitou M, Hérault JP, Bernat A, et al. Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature 1999;398:417-22
   PubMed Web of Science ®Google Scholar
• Parsons CL. Ephthelial coating techniques in the treatment of interstitial cystitis. Urology 1997;49:100-4
   PubMed Web of Science ®Google Scholar
• Fryer A, Huang YC, Rao G, et al. Selective O-desulphation produces non-anticoagulant heparin that retains pharmacologic activity in the lung. J Pharmacol Exp Ther 1997;282:209-19
   Google Scholar
• McLeskey SW, Zhang L, Trock BJ, et al. Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells. Br J Cancer 1996;73:1053-62
   PubMed Web of Science ®Google Scholar
• Gotkin B, Mendoza-Ayala R, Campo C, et al. Effect of heparin tetrasaccharide on late phase responses in ovine and murine models of asthma: comparison with budesonide. Am J Respir Crit Care Med 1999;159:A874
   Google Scholar